Score Overview
See the full market ranking โ
Oncology Institute Inc fundamental performance
Across Oncology Institute Inc's full reported history, from 2021 to 2025, revenue grew from $ 203M to $ 502M and net income went from -$ 10M to -$ 60M. Revenue increased in 100% of the years measured; net income in 80%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-03 | $ 5.13 | โ |
1 Year2025-08-13 | $ 4.10 | 25.12% |
5 Years2021-08-13 | $ 9.94 | -48.39% |
All Time2021-11-15 | $ 9.77 | -47.49% |
| Period | Last Price2026-08-03 | 1 Year2025-08-13 | 5 Years2021-08-13 | All Time2021-11-15 |
|---|---|---|---|---|
| Price | $ 5.13 | $ 4.10 | $ 9.94 | $ 9.77 |
| Return | โ | 25.12% | -48.39% | -47.49% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 545M | -$ 43M | $ 30M |
| 2025 | $ 502M | -$ 60M | $ 33M |
| 2024 | $ 393M | -$ 64M | $ 49M |
| 2023 | $ 324M | -$ 83M | $ 82M |
| 2022 | $ 252M | $ 152K | $ 73M |
| IPO2021 | $ 203M | -$ 10M | $ 114M |
Explore beyond TOI
You're looking at Oncology Institute Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.